» Group Sequential Methods: Applications to Clinical Trials (Chapman & Hall/Crc Interdisciplinary Statistics Series)
Group Sequential Methods: Applications to Clinical Trials (Chapman & Hall/Crc Interdisciplinary Statistics Series) Details
Binding: HardcoverDewey Decimal Number: 615.190727
EAN: 9780849303166
ISBN: 0849303168
Label: Chapman & Hall/CRC
Manufacturer: Chapman & Hall/CRC
Number Of Items: 1
Number Of Pages: 416
Publication Date: 1999-09-15
Publisher: Chapman & Hall/CRC
Studio: Chapman & Hall/CRC
Items related to Group Sequential Methods: Applications to Clinical Trials (Chapman & Hall/Crc Interdisciplinary Statistics Series)
- Analysis of Clinical Trials Using SAS: A Practical Guide
- Statistical Monitoring of Clinical Trials: A Unified Approach (Statistics for Biology and Health)
- Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/Crc Biostatistics)
- Adaptive Design Methods in Clinical Trials (Biostatistics)
- Applied Longitudinal Analysis (Wiley Series in Probability and Statistics)
Group Sequential Methods: Applications to Clinical Trials (Chapman & Hall/Crc Interdisciplinary Statistics Series) Reviews
Customer Rating:




Summary: first good text on group sequential methods
Comment: Advances in the theory of repeated significance testing in the 1980s and 1990s has made sequential methods practical by identifying stopping rules for data collected sequentially but in groups. This material is now used to plan interim analyses and both safety and efficacy group sequential trials for clinical trials. This text provides for the first time thorough coverage of these advances with suitable references to the literature.
It should be on the bookshelf of any biostatistician who conducts clinical trials for pharmaceutical or medical device companies.
Customer Rating:





Summary: clear coverage for practicing biostatisticians
Comment: Advances in the theory of repeated significance testing in the 1980s and 1990s has made sequential methods practical by identifying stopping rules for data collected sequentially but in groups. This material is now used to plan interim analyses and both safety and efficacy group sequential trials for clinical trials. This text provides for the first time thorough coverage of these advances with suitable references to the literature.
It should be on the bookshelf of any biostatistician who conducts clinical trials for pharmaceutical or medical device companies.



